TY - JOUR
T1 - The differences of biological behavior based on the clinicopathological data between resectable large-cell neuroendocrine carcinoma and small-cell lung carcinoma
AU - Kinoshita, Tomonari
AU - Yoshida, Junji
AU - Ishii, Genichiro
AU - Aokage, Keiju
AU - Hishida, Tomoyuki
AU - Nagai, Kanji
N1 - Funding Information:
The authors thank Assistant Professor Roderick J. Turner of Toho University Medical Department and Prof. J. Patrick Barron, Chair of the Department of International Medical Communications of Tokyo Medical University for their editorial review of this report. This work was supported in part by National Cancer Center Research and Development Fund (23-A-18).
PY - 2013/9
Y1 - 2013/9
N2 - Introduction: Large cell neuroendocrine carcinoma of the lung and SCLC are collectively classified as high-grade NECs. However, there have been few reports focusing on the differences of clinicopathological prognostic factors between resectable LCNEC and SCLC. Patients and Methods: We reviewed the clinical data of 140 patients who underwent complete resection of high grade NEC in our institute and analyzed the clinicopathological features in relation to their survival. Results: There were no statistically significant differences in overall and recurrence-free survival between pure and combined subtypes in either LCNEC or SCLC. In LCNEC, larger tumor diameter (P =.01), nodal metastasis (P <.01), lymphatic permeation (P <.01), and vascular invasion (P =.01) were unfavorable prognostic factors. However, in SCLC, tumor diameter and vascular invasion were not prognostic factors, but nodal metastasis (P <.01) and lymphatic permeation (P =.03) were strongly correlated with poor prognosis. Conclusion: There were no apparent differences in biological behavior between pure and combined subtypes in either LCNEC or SCLC. Lymphatic involvement was an important unfavorable prognostic factor in SCLC, whereas tumor diameter, vascular invasion, and lymphatic involvement had a poor prognostic effect in LCNEC.
AB - Introduction: Large cell neuroendocrine carcinoma of the lung and SCLC are collectively classified as high-grade NECs. However, there have been few reports focusing on the differences of clinicopathological prognostic factors between resectable LCNEC and SCLC. Patients and Methods: We reviewed the clinical data of 140 patients who underwent complete resection of high grade NEC in our institute and analyzed the clinicopathological features in relation to their survival. Results: There were no statistically significant differences in overall and recurrence-free survival between pure and combined subtypes in either LCNEC or SCLC. In LCNEC, larger tumor diameter (P =.01), nodal metastasis (P <.01), lymphatic permeation (P <.01), and vascular invasion (P =.01) were unfavorable prognostic factors. However, in SCLC, tumor diameter and vascular invasion were not prognostic factors, but nodal metastasis (P <.01) and lymphatic permeation (P =.03) were strongly correlated with poor prognosis. Conclusion: There were no apparent differences in biological behavior between pure and combined subtypes in either LCNEC or SCLC. Lymphatic involvement was an important unfavorable prognostic factor in SCLC, whereas tumor diameter, vascular invasion, and lymphatic involvement had a poor prognostic effect in LCNEC.
KW - Biological behavior
KW - High grade neuroendocrine carcinomas
KW - Large-cell neuroendocrine carcinoma
KW - Pathological diversity
KW - Prognostic factors
KW - Small-cell lung carcinoma
UR - http://www.scopus.com/inward/record.url?scp=84883782699&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84883782699&partnerID=8YFLogxK
U2 - 10.1016/j.cllc.2013.04.003
DO - 10.1016/j.cllc.2013.04.003
M3 - Article
C2 - 23792008
AN - SCOPUS:84883782699
SN - 1525-7304
VL - 14
SP - 535
EP - 540
JO - Clinical Lung Cancer
JF - Clinical Lung Cancer
IS - 5
ER -